Table 2 from Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors
收藏Figshare2025-03-17 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/Table_2_from_Phase_I_Trial_of_TTI-101_a_First-in-Class_Oral_Inhibitor_of_STAT3_in_Patients_with_Advanced_Solid_Tumors/28606249
下载链接
链接失效反馈官方服务：
资源简介：
Summary of TRAEs reported in >10% of patients treated with TTI-101 monotherapy.
创建时间：
2025-03-17
